78 related articles for article (PubMed ID: 15864916)
1. The dietary supplement ephedrine induces beta-adrenergic mediated exacerbation of systemic lupus erythematosus in NZM391 mice.
Hudson CA; Mondal TK; Cao L; Kasten-Jolly J; Huber VC; Lawrence DA
Lupus; 2005; 14(4):293-307. PubMed ID: 15864916
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of lupus-prone NZM mouse strains to lead exacerbation of systemic lupus erythematosus symptoms.
Hudson CA; Cao L; Kasten-Jolly J; Kirkwood JN; Lawrence DA
J Toxicol Environ Health A; 2003 May; 66(10):895-918. PubMed ID: 12825236
[TBL] [Abstract][Full Text] [Related]
3. Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus.
Shirota Y; Yarboro C; Fischer R; Pham TH; Lipsky P; Illei GG
Ann Rheum Dis; 2013 Jan; 72(1):118-28. PubMed ID: 22858586
[TBL] [Abstract][Full Text] [Related]
4. T-bet
Liu Y; Zhou S; Qian J; Wang Y; Yu X; Dai D; Dai M; Wu L; Liao Z; Xue Z; Wang J; Hou G; Ma J; Harley JB; Tang Y; Shen N
Arthritis Res Ther; 2017 Oct; 19(1):225. PubMed ID: 28982388
[TBL] [Abstract][Full Text] [Related]
5. Abrogation of pathogenic IgG autoantibody production in CD40L gene-deleted lupus-prone New Zealand Black mice.
Pau E; Chang NH; Loh C; Lajoie G; Wither JE
Clin Immunol; 2011 May; 139(2):215-27. PubMed ID: 21414847
[TBL] [Abstract][Full Text] [Related]
6. Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule.
Nakajima A; Azuma M; Kodera S; Nuriya S; Terashi A; Abe M; Hirose S; Shirai T; Yagita H; Okumura K
Eur J Immunol; 1995 Nov; 25(11):3060-9. PubMed ID: 7489744
[TBL] [Abstract][Full Text] [Related]
7. T helper cell subsets in the pathogenesis of systemic lupus erythematosus.
Reininger L; Santiago ML; Takahashi S; Fossati L; Izui S
Ann Med Interne (Paris); 1996; 147(7):467-71. PubMed ID: 9092356
[TBL] [Abstract][Full Text] [Related]
8. β-Adrenergic blockade protects BALB/c mice against infection with a small inoculum of Leishmania mexicana mexicana (LV4).
García-Miss Mdel R; Mut-Martín MC; Góngora-Alfaro JL
Int Immunopharmacol; 2015 Jan; 24(1):59-67. PubMed ID: 25461918
[TBL] [Abstract][Full Text] [Related]
9. B cell apoptosis accelerates the onset of murine lupus.
Trébéden-Nègre H; Weill B; Fournier C; Batteux F
Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
[TBL] [Abstract][Full Text] [Related]
10. Sex hormones and peripheral white blood cell subsets in systemic lupus erythematosus patients.
Rastin M; Hatef MR; Tabasi N; Sheikh A; Morad Abbasi J; Mahmoudi M
Iran J Immunol; 2007 Jun; 4(2):110-5. PubMed ID: 17652851
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effect of polyclonal immunoglobulins from malaria-infected BALB/c mice on the lupus-like syndrome of (NZB x NZW)F1 mice.
Hentati B; Sato MN; Payelle-Brogard B; Avrameas S; Ternynck T
Eur J Immunol; 1994 Jan; 24(1):8-15. PubMed ID: 8020574
[TBL] [Abstract][Full Text] [Related]
12. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
Enghard P; Langnickel D; Riemekasten G
Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
[TBL] [Abstract][Full Text] [Related]
13. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
Pavón EJ; Zumaquero E; Rosal-Vela A; Khoo KM; Cerezo-Wallis D; García-Rodríguez S; Carrascal M; Abian J; Graeff R; Callejas-Rubio JL; Ortego-Centeno N; Malavasi F; Zubiaur M; Sancho J
Cytokine; 2013 May; 62(2):232-43. PubMed ID: 23538292
[TBL] [Abstract][Full Text] [Related]
14. Autoimmunity develops in lupus-prone NZB mice despite normal T cell tolerance.
Wither J; Vukusic B
J Immunol; 1998 Nov; 161(9):4555-62. PubMed ID: 9794382
[TBL] [Abstract][Full Text] [Related]
15. Maintenance of autoantibody production in pristane-induced murine lupus.
Han S; Zhuang H; Xu Y; Lee P; Li Y; Wilson JC; Vidal O; Choi HS; Sun Y; Yang LJ; Reeves WH
Arthritis Res Ther; 2015 Dec; 17():384. PubMed ID: 26717913
[TBL] [Abstract][Full Text] [Related]
16. A dose-escalation study of rituximab for treatment of systemic lupus erythematosus and Evans' syndrome: immunological analysis of B cells, T cells and cytokines.
Tamimoto Y; Horiuchi T; Tsukamoto H; Otsuka J; Mitoma H; Kimoto Y; Nakashima H; Muta K; Abe Y; Kiyohara C; Ueda A; Nagasawa K; Yoshizawa S; Shimoda T; Harada M
Rheumatology (Oxford); 2008 Jun; 47(6):821-7. PubMed ID: 18397955
[TBL] [Abstract][Full Text] [Related]
17. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus.
Lartigue A; Colliou N; Calbo S; François A; Jacquot S; Arnoult C; Tron F; Gilbert D; Musette P
J Immunol; 2009 Nov; 183(10):6207-16. PubMed ID: 19841185
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help.
Sanders VM; Baker RA; Ramer-Quinn DS; Kasprowicz DJ; Fuchs BA; Street NE
J Immunol; 1997 May; 158(9):4200-10. PubMed ID: 9126981
[TBL] [Abstract][Full Text] [Related]
19. IgG1 and IgG2a production by autoimmune B cells treated in vitro with IL-4 and IFN-gamma.
Klinman DM
J Immunol; 1990 Apr; 144(7):2529-34. PubMed ID: 2108205
[TBL] [Abstract][Full Text] [Related]
20. Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice.
Nakajima A; Hirose S; Yagita H; Okumura K
J Immunol; 1997 Feb; 158(3):1466-72. PubMed ID: 9013993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
